NewAmsterdam Pharma
Developing transformative, clinically validated oral therapies for patients with metabolic diseases.
Launch date
Employees
Market cap
$1.4b
Enterprise valuation
$1.0b (Public information from Sep 2024)
Share price
$16.06 NAMS
Naarden North Holland (HQ)
Authorizing premium user...